Michel Andréjak
- Cardiology and Cardiovascular Medicine top 5%
- Surgery top 10%
- Pharmacology top 5%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- L HaryHenri MassonChristophe TribouilloyZiad A. MassyKamel MasmoudiValérie Gras‐ChampelValérie GrasMarcel Peltier
- Topics
- Pharmacological Effects and Toxicity Studies (12 papers)Antibiotics Pharmacokinetics and Efficacy (10 papers)Pharmacology and Obesity Treatment (9 papers)
- Partner nations
- FranceUnited StatesSwitzerland
In The Last Decade
Michel Andréjak
111 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 113
- Cardiology and Cardiovascular Medicine 426
- Surgery 396
- Pharmacology 219
- Molecular Biology 210
- Pulmonary and Respiratory Medicine 202
Countries citing papers authored by Michel Andréjak
This map shows the geographic impact of Michel Andréjak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Andréjak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Andréjak more than expected).
Fields of papers citing papers by Michel Andréjak
This network shows the impact of papers produced by Michel Andréjak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Andréjak. The network helps show where Michel Andréjak may publish in the future.
Co-authorship network of co-authors of Michel Andréjak
This figure shows the co-authorship network connecting the top 25 collaborators of Michel Andréjak. A scholar is included among the top collaborators of Michel Andréjak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Andréjak. Michel Andréjak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 10 | |
| 3 | 30 | |
| 4 | 6 | |
| 5 | 10 | |
| 6 | 21 | |
| 7 | 147 | |
| 8 | 7 | |
| 9 | 12 | |
| 10 | 1 | |
| 11 | 72 | |
| 12 | Etude pharmaco-clinique comparative de la ceftriaxone par voie sous-cutanée et intraveineuse chez la personne âgée | 13 |
| 13 | [Rhabdomyolysis associated to fenoverin therapy and complicated by acute renal failure]. | 2 |
| 14 | [Neurologic side effects of fluoroquinolones. Apropos of 9 cases concerning pefloxacin]. | 6 |
| 15 | 10 | |
| 16 | 12 | |
| 17 | 37 | |
| 18 | 17 | |
| 19 | 8 | |
| 20 | [Beta-blockaders in the treatment of arterial hypertension. Part I. Pharmacologic, hemodynamic and metabolic aspects]. | 1 |
About Michel Andréjak
Michel Andréjak is a scholar working on Toxicology, Pharmacology and Nephrology, having authored 115 papers that have together received 1.6k indexed citations. Recurring topics across this work include Pharmacological Effects and Toxicity Studies (12 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Pharmacology and Obesity Treatment (9 papers). The work is most often cited by research in Nephrology (201 citations), Toxicology (89 citations) and Cardiology and Cardiovascular Medicine (426 citations). Michel Andréjak has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include L Hary, Henri Masson, Christophe Tribouilloy, Ziad A. Massy, Kamel Masmoudi, Valérie Gras‐Champel, Valérie Gras, Marcel Peltier, Michel Slama and Gabriel Choukroun. Their work appears in journals such as Circulation, CHEST Journal and European Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.